Αποτελέσματα Αναζήτησης
1 Μαρ 2022 · This systematic review summarizes the literature examining the possible clinical benefits of EDTA chelation therapy in patients with preexistent cardiovascular disease. This is the largest review to date, including 4 clinical trials, 15 prospective before/after studies, and 5 retrospective case series assessing mortality, disease severity ...
- View Epub
View Epub - Chelation Therapy in Patients With...
- View Epub
This fact sheet describes chelation therapy for coronary heart disease and the research done on it, including two large studies funded by the National Institutes of Health (NIH).
13 Ιουν 2023 · Some researchers say chelation therapy can treat heart disease because the medicine may stick to — and remove — calcium found in deposits that clog arteries. However, chelation therapy for heart disease remains controversial.
Key findings. Twenty-four studies (15 prospective studies, 5 retrospective case series, 4 randomized clinical trials) assessed repeated ethylenediaminetetra-acetic acid (EDTA) chelation treatment in patients with preexistent cardiovascular disease.
Chelation therapy is promoted as a form of alternative medicine to treat atherosclerosis and relieve symptoms of cardiovascular disease . It has been suggested to be a safe, relatively inexpensive, non‐surgical method of restoring blood flow in atherosclerotic vessels, thus preventing chronic symptoms such as angina pectoris and claudication ...
1 Μαρ 2022 · Background. EDTA is an intravenous chelating agent with high affinity to divalent cations (lead, cadmium, and calcium) that may be beneficial in the treatment of cardiovascular disease (CVD). Although a large randomized clinical trial showed benefit, smaller studies were inconsistent.
Chelation therapy, defined as repeated intravenous administration of ethylenediamine tetraacetic acid (EDTA) with or without vitamins, trace elements, or iron supplements for the treatment of CHD. Studies with or without control groups were included.
